Work

RXÂ 3117: Activity of an oral antimetabolite nucleoside in subjects with pancreatic cancerâ€“Preliminary results of stage II of the phase Ia/IIb study.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.4_suppl.396

Authors: Vincent M. Chung, Jaime R. Merchan, Allyson J. Ocean, Drew W. Rasco, Hani M. Babiker, Ira Oliff, Ravi Kumar Paluri, Eloy Roman, Julie Poore, Ely Benaim

Institutions: City Of Hope National Medical Center, University of Miami, Weill Cornell Medicine, South Texas Accelerated Research Therapeutics, University of Arizona Cancer Center, University of Alabama at Birmingham

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2797547417

Cites:

Cited by: 1

Related to: 10